Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cordis
MedTech
Cordis absorbs drug-eluting balloon maker MedAlliance for $235M
The transaction for the Swiss manufacturer MedAlliance could total as much as $1.1 billion over the next seven years.
Conor Hale
Oct 20, 2022 11:38am
InnovHeart nabs J&J, Haemonetics alum as CEO
Mar 30, 2022 11:28am
FDA stamps Class I label on Cordis angiographic catheter recall
Sep 24, 2021 12:16pm
Cardinal Health to sell its Cordis device division in $1B deal
Mar 15, 2021 9:30am
FDA panel backs Cordis’ Incraft stent graft for aortic aneurysms
Jun 13, 2018 11:00am
Medical device woes torpedo Cardinal Health’s results
May 4, 2018 8:35am
